Buscar

Source:

Johnson MW, Naudé GP, Hendricks PS, Garcia-Romeu A. Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2026;9(3):e260972. doi:10.1001/jamanetworkopen.2026.0972

 

Key Points

Que...

 

Free eBook on How to Integrate Wellness into Drug Prevention

 

The purpose of this eBook is to gain an understanding of wellness and its essential role in substance use prevention practice for enhancing the mental and physical...

Abstract

Importance  As cannabis becomes more accessible and socially accepted, concerns have grown about its potential implications for adolescent mental health. While prior research has linked adolescent cannabis use to psychiatric...

Abstract

PURPOSE: Alcohol misuse is widely accepted as an independent risk factor for a wide variety of lung diseases, such as pneumonia and acute respiratory distress syndrome. Alcohol induces changes in the regulatory mechanisms of the...

Abstract

Background

Buprenorphine is an effective medication for treating opioid use disorder but is underutilized partly due to patient apprehensiveness of the severe withdrawal symptoms it can induce when started, particularly by...

Abstract

Importance  Retention on methadone and buprenorphine has been shown to be associated with reduced overdose and death. Opioid treatment programs (OTPs) are the only health care facilities in the US licensed to dispense methadone...

Abstract

Importance  The requirement for in-person, often daily, attendance at opioid treatment programs (OTPs) makes travel times a barrier to methadone treatment. Research on methadone accessibility has primarily focused on travel via...

A quarter of 11-year-old children in the USA have tried alcohol, typically provided by parents. Parents are the primary source of alcohol socialization for preteens, yet many are unaware of their influence and lack tools to discourage early...

 

AGENDA

2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices

FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics

Topic 1: Large Language Models in...

The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...

The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals

Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of Interv...

I’m seeing a rise in fentanyl-contaminated cocaine across New York City, Long Island, and the Hudson Valley. I share real cases, warning signs, and harm-reduction strategies families can use—including free 22-panel tests—to prevent fatal overdoses.

Background

The opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides...

Background. Substance use disorders (SUDs) remain a major global health burden. Neurostimulation has emerged as a promising treatment by directly altering brain circuits implicated in addictive behaviors, but current methods are limited in...

Cocaine-related harms on Long Island (Nassau & Suffolk) are increasingly polysubstance, with fentanyl present in most fatal cocaine overdoses in New York. Nationally, cocaine-involved mortality has nearly doubled since 2018. This fact sheet compiles verified NY/CDC sources and practical steps for families and providers: carry and train on naloxone, arrange benefits/transport to speed placement, screen for co-occurring mental health, and use evidence-based care (Contingency Management + CBT).

This article presents key studies from the National Institute of Justice’s (NIJ) Courts Research Portfolio that examine pretrial, prosecution, and sentencing policies promoting alternatives to incarceration, such as Veterans Treatment...

ABSTRACT

Background

There is a gap between evidence-based treatment with medications for opioid use disorders (OUDs) and current practices of probation departments who supervise individuals with OUDs. Many probationers with OUDs cannot...

Abstract

Background and objectives: Drug courts provide an array of substance use treatments and community-based services for probationers struggling with substance use disorders. We assessed substance use treatment services utilization...

Highlights

• Motivational computer intervention (MAPIT) increased treatment initiation at 2-month follow-up.
• The significance of MAPIT diminished by the 6-month follow-up.
• Motivational interviewing (MI) was not significant in any model.
...

Abstract

Background

Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid...